DS Healthcare Group, Inc. (fka DSKX)

[wkpeters]

Divine Skin Initiated at Outperform by Zacks Investment Research

MIAMI BEACH, Fla., June 14, 2010 / DIVINE SKIN INC. (OTC Bulletin Board: DSKX), a newly public cosmeceutical developer specializing in topical skin care and hair regrowth, announced that Zacks Investment Research had initiated coverage of the company with an "outperform" recommendation and a six-month target price of $0.50, covered by Analyst Claudio Freitas, CFA.
Divine Skin grew quickly without investment capital until 2009, when it conducted its first private placement. It began trading May 20th, 2010.

The company's strategy is to combine active ingredients that already have US Food and Drug Administration monographs, thus avoiding lengthy approvals while achieving efficacy and delivering new products quickly. The company's first brand, DS Laboratories, established itself with comprehensive minoxidil-based and minoxidil-free products.

Last week, DS Laboratories announced a new agreement for its DS Laboratories brand to supply hair-growth products through Premier Salons, one of North America's largest chains, with about 3,000 locations. It also announced the distribution of its DS Laboratories brand to Fantastic Sams chain, with more than 1,300 franchised salons locations in the United States. So far demand has exceeded expectations.

The full report can be viewed at: http://www.proactivenewsroom.com/ds-laboratories-inc